Form D · Hedge Fund

Euclidean Fund For Cancer Research LP

Seattle, WA · CIK 0001729236

Offering snapshot reported Oct 4, 2022 · SEC filing

Reported sold
$13.4M
Indefinite offering
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 1, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.71M$13.4MMay 1, 2018: $3,746,999.00May 1, 2018May 1, 2019: $10,424,999.00May 1, 2019Oct 7, 2019: $10,424,999.00Oct 7, 2020: $10,424,999.00Oct 7, 2020Oct 7, 2021: $13,424,999.00Oct 7, 2021Oct 4, 2022: $13,424,999.00Oct 4, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 4, 2022Amendment$13,424,999$0vs Oct 7, 20218SEC filing
Oct 7, 2021Amendment$13,424,999$3,000,000vs Oct 7, 20208SEC filing
Oct 7, 2020Amendment$10,424,999$0vs Oct 7, 20198SEC filing
Oct 7, 2019Amendment$10,424,999$0vs May 1, 20198SEC filing
May 1, 2019Amendment$10,424,999$6,678,000vs May 1, 20188SEC filing
May 1, 2018Initial$3,746,999No comparison8SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06c, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-311389

Source: Form D, filed Oct 4, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

THE EUCLIDEAN FUND FOR CANCER RESEARCH LP

Investment adviser: EUCLIDEAN TECHNOLOGIES MANAGEMENT, LLC

Gross asset value
$13.9M
Beneficial owners
9
ADV minimum commitment
$1M

Reported in Form ADV on Mar 21, 2023. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALPS ALTERNATIVE INVESTMENT SERVICES, LLC DENVER, Colorado, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor MARCUM LLP NEW YORK, New York, United States
Custodian GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: No
Prime broker COWEN EXECUTION SERVICES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

MARCUM LLP
PCAOB 5395

GOLDMAN SACHS & CO. LLC
SEC 8-129

COWEN EXECUTION SERVICES LLC
CRD 35693 · SEC 8-46838

Filing source

Form ADV 1716567 · Mar 21, 2023 · Schedule D 7.B.(1), fund 805-6707100031

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Euclidean Technologies Gp, Llc Executive, Promoter
Euclidean Technologies Management, Llc Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
Euclidean Technologies Management, Llc 701 5 Th Avenue, Suite 4200
Seattle, WA, 98104